Found vs Noom Med: Medical Weight-Loss Programs Compared Head-to-Head

Last reviewed: September 12, 2026 Last updated: September 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found and Noom Med use fundamentally different commercial models. Found bundles medication, clinical care, and app-based support into a single monthly rate—$289/month semaglutide or $359/month tirzepatide on month-to-month cash plans—and offers insurance-eligible plans starting at $199/month (plus copays) or $99/month effective when prepaid annually. Noom Med separates clinical support ($129/month billed quarterly, medication excluded) from medication costs; its microdose GLP-1 program has a first-month introductory rate of $79, then $179/month ongoing. Found's model suits people who want predictable all-in pricing or who carry insurance; Noom Med's structure may appeal to those already on a behavior-change plan who want to add medication separately. PlexusDx offers compounded semaglutide injection at $189/month with no separate membership fee, sitting between Found's cash rates and Noom's microdose ongoing cost.

At-a-glance comparison

Sources: Found.com (captured 2026-07-20, 2026-09-04, 2026-09-12), Noom.com (captured 2026-09-04), PlexusDx.com (captured 2026-07-20), Trustpilot (captured 2026-09-04, 2026-09-09).

Pricing structures: all-in vs unbundled

Found's cash-pay plans bundle compounded medication, clinical care, and app access into a single recurring charge. Month-to-month rates are $289 for semaglutide injection and $359 for tirzepatide injection, billed every four weeks (thirteen charges per year). Found also offers three-month, six-month, and twelve-month prepaid plans; the twelve-month semaglutide plan costs $2,028 upfront ($169/month effective), and the twelve-month tirzepatide plan is billed at $239/month effective when prepaid annually. All Found cash plans are HSA/FSA eligible, and the company offers a full refund if a patient is not clinically eligible.

Found's insurance track is a separate product line. The month-to-month insurance plan costs $199/month plus typical copays around $30 per visit; visits on the insurance track are synchronous video consultations. Found also offers a twelve-month insurance prepaid plan at $1,188 upfront ($99/month effective), plus copays. The final price "varies based on medication, insurance and coverage," and Found reports in-network clinicians for one in three Americans.

Noom Med separates clinical support from medication cost. The Core Med program is $129/month, billed quarterly ($387 every three months after the first month), and includes behavior-change programming and clinician access but excludes medication. Patients purchase medication separately—either branded GLP-1s through insurance or compounded formulations at rates determined during the eligibility flow. Noom Med's microdose GLP-1Rx program, by contrast, bundles medication and clinical support: a first-month introductory rate of $79 covers three weeks of subscription plus four weeks of medication, followed by an ongoing rate of $179/month for a twelve-week subscription. Noom does not publish standard-dose compounded semaglutide or tirzepatide cash rates outside the microdose program.

PlexusDx bundles compounded medication, provider visit, and shipping into a single monthly rate with no separate membership fee. Semaglutide injection is $189/month month-to-month, $169/month at the three-month rate, and $149/month at the six-month rate. Tirzepatide injection is $289/month month-to-month, $269/month at the three-month rate, and $249/month at the six-month rate. PlexusDx bills on the calendar month (twelve charges per year) and offers the same price at every dose.

Twelve-month cost comparison

Normalizing to twelve months of treatment highlights the impact of prepayment, billing cadence, and bundling decisions. All figures below are our calculations based on published rates and stated billing cycles.

Found – Cash-Pay Semaglutide

• Month-to-month: $289/month × 12 calendar months = $3,468 per year (our calculation; Found bills every 4 weeks, resulting in 13 charges annually; actual annual cost approximately $3,757)
• Twelve-month prepaid: $2,028 upfront = $169/month effective, or $2,028 total
• Difference: Prepaying saves approximately $1,729 over twelve months compared to the published month-to-month cash rate on a calendar-year basis ($3,468 vs $2,028)

Found – Cash-Pay Tirzepatide

• Month-to-month: $359/month × 12 = $4,308 per year (our calculation; actual annual cost approximately $4,667 due to 13 billing cycles)
• Twelve-month prepaid: $239/month effective when billed annually = $2,868 per year
• Difference: Prepaying saves approximately $1,440 annually on a calendar-year basis ($4,308 vs $2,868)

Found – Insurance Track

• Month-to-month insurance plan: $199/month × 12 = $2,388, plus copays (approximately $30 per visit; total copay cost depends on visit frequency)
• Twelve-month insurance prepaid: $1,188 upfront ($99/month effective), plus copays
• Effective total: If a patient has one visit per month, add approximately $360 in copays to either plan; two visits per month would add approximately $720

Noom Med – Microdose GLP-1Rx

• Year one with first-month rate: $79 (month one) + $179/month × 11 = $2,048
• Year two onward: $179/month × 12 = $2,148

Noom Med – Core Med + Medication

• Core Med program alone: $129/month × 12 = $1,548 per year
• Medication cost: Not published; total cost determined at eligibility and checkout

PlexusDx – Semaglutide Injection

• Month-to-month: $189/month × 12 = $2,268 per year
• Six-month rate: $149/month × 12 = $1,788 per year

PlexusDx – Tirzepatide Injection

• Month-to-month: $289/month × 12 = $3,468 per year
• Six-month rate: $249/month × 12 = $2,988 per year

Found's twelve-month cash prepaid semaglutide plan ($2,028) and Noom Med's microdose first-year effective cost ($2,048) are nearly identical. PlexusDx's six-month semaglutide rate ($1,788/year) is lower than both. Found's insurance prepaid plan ($1,188 plus copays) may be the lowest total cost for patients with strong coverage, but the final figure depends on visit frequency and copay structure. For tirzepatide, PlexusDx's six-month rate ($2,988/year) is $120 more per year than Found's twelve-month prepaid rate ($2,868/year when billed annually at $239/month effective).

Medication options and formats

Found offers compounded semaglutide and tirzepatide injections included in the plan price. Branded medications—Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, and Foundayo (orforglipron)—are available but billed separately. Metformin is also available. All compounded medications are supplied by licensed compounding pharmacies.

Noom Med offers branded GLP-1 injections (subject to insurance coverage), compounded GLP-1 programs, and a microdose GLP-1 program. Product and formulation details require completion of the eligibility flow; the company does not publish standard-dose compounded semaglutide or tirzepatide cash rates on its public pricing pages.

PlexusDx offers compounded semaglutide and tirzepatide in both injection and oral-capsule formats, plus a microdose injection protocol at $129/month. All compounded medications are prepared by licensed 503A compounding pharmacies. PlexusDx does not offer branded medications or insurance billing.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Support models and service differences

Found centers its service around 24/7 access to a care team through a proprietary app, personalized care plans, healthy-habits guidance, and an AI concierge named Aimee. The insurance track includes synchronous video visits; the cash track does not specify visit format. Found reports "in-network clinicians for 1 in 3 Americans."

Noom Med is built on a behavior-change platform with clinician access integrated into the Core Med program. The company's review profile reflects its broader weight-loss coaching history (67,000 reviews profile-wide on Trustpilot, 4.5 stars, captured September 4, 2026). The microdose program bundles clinical oversight with medication; the Core Med program separates the two.

PlexusDx includes a free Doctor of Pharmacy check-in with every protocol and offers an optional DNA-informed dosing support add-on ($99 for program members, $298 general retail). The service model emphasizes precision dosing informed by genetic data and ongoing pharmacist consultation rather than app-based coaching or behavior-change programming.

Review records

Found holds a 4.1-star rating on Trustpilot across approximately 732 reviews (captured September 4, 2026). Individual Trustpilot reports describe delays in medication shipment, difficulty reaching customer support, and billing confusion; other reviews cite effective weight loss and responsive care teams. Because Trustpilot reviews are individual accounts, they should be read as anecdotes rather than established service patterns.

Noom Med's Trustpilot profile reflects the company's full product suite, not the Med program in isolation; the 4.5-star rating across 67,000 reviews (captured September 4, 2026) includes feedback on the core weight-loss coaching app, which predates the medication programs.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Choose Found if…

• You carry insurance that covers telehealth weight-loss visits and prefer video consultations; Found's insurance track is $199/month (or $99/month effective when prepaid annually) plus copays.
• You want an all-in cash price with 24/7 app-based support and are willing to prepay to lower the effective monthly rate; Found's twelve-month semaglutide plan is $2,028 upfront ($169/month effective).
• You value a single platform for medication, care team access, and habit coaching, and don't want to coordinate multiple vendors.
• You're considering branded medications (Ozempic, Wegovy, Mounjaro, Zepbound) alongside compounded options and want a provider that offers both.

Choose Noom Med if…

• You want a structured behavior-change program with clinician access and prefer to purchase medication separately; Core Med is $129/month billed quarterly, medication excluded.
• You're exploring microdose GLP-1 therapy; Noom's microdose program has a first-month rate of $79, then $179/month ongoing, and includes medication in the subscription price.
• You're already familiar with Noom's coaching platform and want to add medical weight-loss support to an existing routine.
• You prefer to evaluate medication options (branded vs compounded, standard vs microdose) within an eligibility flow rather than committing to a single format upfront.

Where PlexusDx fits

PlexusDx sits between Found's cash rates and Noom's microdose ongoing cost for month-to-month plans. Semaglutide injection is $189/month at PlexusDx versus $289/month at Found (cash, month-to-month) and $179/month at Noom (microdose, after first-month rate); tirzepatide injection is $289/month at PlexusDx versus $359/month at Found. PlexusDx's six-month rates—$149/month semaglutide, $249/month tirzepatide—are lower than Found's twelve-month prepaid equivalents and require less upfront commitment ($894 every six months for semaglutide versus $2,028 annually at Found).

PlexusDx does not offer insurance billing, app-based coaching, or 24/7 care-team chat. The service model centers on pharmacist consultation and optional DNA-informed dosing support rather than behavior-change programming. Patients who want the lowest cash price for compounded semaglutide or tirzepatide without a large upfront payment, and who don't need app-based habit tracking, may find PlexusDx a simpler fit than Found's prepaid structure or Noom's unbundled model.

Methodology and freshness

We captured Found's pricing from Found.com on July 20, September 4, and September 12, 2026. Noom Med's Core Med and microdose rates were captured from Noom.com on September 4, 2026. PlexusDx pricing was verified on July 20, 2026. Trustpilot ratings for Found and Noom Med were captured September 4, 2026; PlexusDx's Trustpilot rating was captured September 9, 2026. All twelve-month cost calculations, prepaid per-month equivalents, and billing-cycle adjustments are our calculations based on the published rates and stated billing cadences. We did not use promotional offers, referral links, or special pricing; all prices reflect standard public rates at capture. Noom Med's standard-dose compounded semaglutide and tirzepatide cash pricing was not available on public pages; the Core Med + medication model reflects the structure described on Noom.com, but the final medication cost is determined during eligibility. Found's insurance-track final cost depends on individual coverage, copay structure, and visit frequency; the $199/month and $99/month figures exclude copays. Where evidence conflicts or remains incomplete, we state the conflict and advise confirming at checkout.

Frequently Asked Questions

Does Found include medication in the monthly price?

Yes, on Found's cash-pay plans. Compounded semaglutide and tirzepatide are included in the $289/month and $359/month rates (month-to-month) or lower prepaid equivalents. Branded medications—Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Foundayo—are billed separately. On Found's insurance track, medication coverage depends on your plan; the $199/month or $99/month program fee is separate from medication and copay costs.

What is Noom Med's Core Med program, and does it include medication?

Noom Med's Core Med program is $129/month, billed quarterly, and includes behavior-change programming and clinician access but excludes medication. Patients purchase medication separately—either branded GLP-1s through insurance or compounded formulations at rates determined during eligibility. Noom's microdose GLP-1 program, by contrast, bundles medication and support at $179/month after a first-month rate of $79.

How does Found's four-week billing cycle affect annual cost?

Found's month-to-month cash plans bill every four weeks, resulting in thirteen charges per year instead of twelve. A $289/month semaglutide plan costs approximately $3,757 annually (our calculation: $289 × 13), not $3,468. Found's prepaid plans—three-month, six-month, twelve-month—eliminate this issue by setting a fixed term and total upfront cost.

Can I use insurance with PlexusDx?

No. PlexusDx is a cash-pay service and does not bill insurance or process claims. All published rates are out-of-pocket prices. PlexusDx medications are HSA/FSA eligible, but you must submit claims yourself. Found offers a separate insurance track; Noom Med supports insurance for branded medications only.

Which program offers the lowest effective monthly cost for semaglutide?

Over twelve months, PlexusDx's six-month semaglutide rate ($149/month, $1,788/year) is the lowest cash price in this comparison. Found's twelve-month insurance prepaid plan ($99/month effective, $1,188 upfront plus copays) may be lower if your insurance covers telehealth visits and your copays are modest, but the final cost depends on visit frequency and your plan's copay structure.

Sources

• Found.com – pricing, inclusions, billing cadence, cancellation policy (captured July 20, 2026; September 4, 2026; September 12, 2026)
• Noom.com – Core Med pricing, microdose GLP-1 pricing, program structure (captured September 4, 2026)
• PlexusDx.com – pricing, inclusions, billing cadence (captured July 20, 2026)
• Trustpilot.com/review/found.com – 4.1 stars, ~732 reviews (captured September 4, 2026)
• Trustpilot.com/review/noom.com – 4.5 stars, 67K reviews profile-wide (captured September 4, 2026)
• Trustpilot.com/review/plexusdx.com – 4.3 stars, 79% five-star, 83% four stars or higher (captured September 9, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.